Skip to main content
. 2011 Aug 2;6(8):e22635. doi: 10.1371/journal.pone.0022635

Figure 2. Antiviral activity of GRFT-pretreated PBMC for R5 HIV-1 BaL infection.

Figure 2

Freshly isolated PBMC from 3 different donors were pretreated with GRFT (394-0.13 nM) and maraviroc (2 µM) for 24 hrs and then washed and infected with the R5 HIV-1 BaL strain for 9 days. No compounds were added during the infection and viral replication was measured by p24 Ag specific ELISA in the collected supernatants.